NCBI . NLM . NIH . GOV {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Ncbi.nlm.nih.gov Make Money
Keywords
Topics
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC3025451/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC3025451/. The analysis below is for the second page.

Title[redir]:
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer - PMC
Description:
The EML4-ALK fusion gene has been detected in ~7% of Japanese non-small cell lung cancers (NSCLC). We determined the frequency of EML4-ALK in Caucasian NSCLCs and in NSCLC cell lines. We also determined whether TAE684, a specific ALK kinase ...

Matching Content Categories {📚}

Science
Education
Telecommunications

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't tell how the site generates income.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Ncbi.nlm.nih.gov might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

cell, emlalk, alk, doi, tae, nsclc, lines, cancer, kinase, growth, patients, egfr, fusion, dfci, line, lung, pubmed, google, scholar, gene, tumors, cells, detected, treatment, inhibition, fig, apoptosis, tumor, exon, variant, inhibitor, inhibitors, data, akt, phosphorylation, combination, shown, erlotinib, erk, studies, array, erbb, eml, frozen, probes, significant, effects, gefitinib, pmc, stat,

Topics {✒️}

supplementary materials nihms263091-supplement-supplement_1 supplementary material nihms263091-supplement-supplement_1 anaplastic large-cell lymphoma small extra-chromosomal fragment phospho-receptor tyrosine kinase bcr-abl tyrosine kinase small-cell lung cancer anaplastic large-cell lymphomas pmc beta search irreversible pan-erbb inhibitor paraffin embedded slides anti-α-tubulin antibody c-terminal kinase domain npm-alk mediated lyphomagenesis eml4-alk fusion gene gefitinib-sensitizing egfr mutations eml4-alk fusion signal 25 mg/kg/day dose receptor tyrosine kinases receptor tyrosine kinase eml4-alk fusion genes eml4-alk cell line small-cell lung anaplastic lymphoma kinase tae684 10 mg/kg/day tae684 25 mg/kg/day supplementary materials included hematoxylin/eosin-stained slides human lung carcinomas rneasy mini kit lung cancer jussi detected eml4-alk fusion multiple signaling pathways cytoreductive antitumor activity chemotherapy naïve female entire kinase domain necrotic tumor tissues small-molecule inhibitor rna isolation kit egfr/erbb2 kinase inhibitor gamma satellite dna natl cancer inst detected eml4-alk significantly lung cancer models samsung medical center small molecule inhibitors small-molecule inhibitors phospho-rtk array comprising 25 mg/kg/day 10 mg/kg/day

Social Networks {👍}(6)

External Links {🔗}(73)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager

Libraries {📚}

jQuery
jQuery module (jquery-3.6.0)
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

nihcesxway.hub.nih.gov
nihcesxway2.hub.nih.gov
nihcesxway3.hub.nih.gov
nihcesxway4.hub.nih.gov
nihcesxway5.hub.nih.gov

Name Servers:

dns1-ncbi.ncbi.nlm.nih.gov
dns2-ncbi.ncbi.nlm.nih.gov
lhcns1.nlm.nih.gov
lhcns2.nlm.nih.gov

CDN Services {📦}

Ncbi

3.43s.